tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market
ORMP
Oramed Pharm
RESEARCH TOOLSreports
Want to see ORMP full AI Analyst Report?

Oramed Pharm (ORMP) Financial Statements

535 Followers

Oramed Pharm Financial Overview

Oramed Pharm's market cap is currently $166.57M. The company's EPS TTM is $2.65; its P/E ratio is 1.54; Oramed Pharm is scheduled to report earnings on July 15, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Sep 23Dec 22Aug 21
Income Statement
Total Revenue$ 2.00M$ 0.00$ 1.34M$ 2.70M$ 2.70M
Gross Profit$ 13.00K$ -193.00K$ 1.34M$ 2.70M$ 2.70M
Operating Income$ -15.09M$ -12.78M$ -15.77M$ -40.60M$ -24.22M
EBITDA$ 75.44M$ -14.87M$ 7.32M$ -36.98M$ -25.04M
Net Income$ 64.05M$ -19.10M$ 5.53M$ -37.76M$ -22.24M
Balance Sheet
Cash & Short-Term Investments$ 125.89M$ 141.93M$ 162.05M$ 155.72M$ 94.14M
Total Assets$ 230.86M$ 155.28M$ 220.55M$ 161.64M$ 128.00M
Total Debt$ 825.00K$ 372.00K$ 51.62M$ 894.00K$ 533.00K
Net Debt$ -45.12M$ -54.05M$ 42.57M$ -39.57M$ -76.71M
Total Liabilities$ 31.12M$ 9.93M$ 57.66M$ 10.49M$ 11.48M
Stockholders' Equity$ 199.74M$ 146.26M$ 163.82M$ 151.81M$ 115.77M
Cash Flow
Free Cash Flow$ -11.08M$ -8.43M$ -10.55M$ -29.20M$ -21.56M
Operating Cash Flow$ -9.14M$ -8.41M$ -10.29M$ -28.70M$ -21.18M
Investing Cash Flow$ 5.44M$ 105.82M$ -73.04M$ 30.21M$ -22.26M
Financing Cash Flow$ -4.74M$ -52.04M$ 51.98M$ 11.56M$ 101.39M
Currency in USD

Oramed Pharm Earnings and Revenue History

Income Statement >

Oramed Pharm Debt to Assets

Balance Sheet >

Oramed Pharm Cash Flow

Cash Flow >

Oramed Pharm Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >